ME1 — Melodiol Global Health Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- AU$0.01m
- AU$8.96m
- AU$19.60m
Brief: Creso Pharma Says Replacement Of Chairman
Brief: Creso Pharma Says Mernova Secures Cannabis 2.0 Sales License
Australia's Creso Pharma rises after unit secures cannabis sales licence
Brief: Creso Pharma Records Qtrly Total Group Revenue Of A$2.1 Million
Australia's Creso Pharma jumps on plans of equity raising, revenue boost
Brief: Creso Pharma Secures Commitments To Raise Up To A$7.6M
Brief: Creso Pharma Seeks Trading Halt
Australia's Creso Pharma higher after deal to raise brand awareness
Brief: Creso Pharma Says Unit Entered Into Product Supply And Services Agreement With Accelerate360
Brief: Creso Pharma Says Unit Expands Into Canadian Medicinal Cannabis Market
Brief: Creso Pharma Says Unit Got Research Ethics Board Approval For Patient Recruitment For Phase II Clinical Trial For Psilocybin
Brief: Creso Pharma Says Sierra Sage Secures $214,000 Purchase Order From Walmart
Brief: Creso Pharma Posts HY Revenue From Ordinary Activities A$4.3 Million
Australia's Creso Pharma falls most in over 5 months on discounted placement
Brief: Creso Pharma To Raise A$7m Equity At Issue Price Of A$0.04 Per Share
Brief: Creso Pharma Signs Non-Binding Term Sheet To Acquire Health House International
Brief: Creso Pharma Seeks Trading Halt
Australia's Creso Pharma rises on unit expanding PTSD drug trial
Secures Commercialisation Letter Of Intent With Providence Animal Health Korea Ltd